A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections

Skin and Subcutaneous Tissue Bacterial Infections Clinical Trial

Official title:
A Phase 2 Exploratory Study of Objective Endpoints in Subjects With Acute Bacterial Skin and Skin Structure Infections Treated With Delafloxacin, Vancomycin, or Linezolid

Status Completed

Clinical Trial Summary

The purpose of this study is to compare clinical response to the measurement techniques of several objective measures of clinical efficacy for use in future ABSSSI (Acute Bacterial Skin and Skin Structure Infection) clinical trials

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Bacterial Infections
Communicable Diseases
Infection
Skin and Subcutaneous Tissue Bacterial Infections

Clinical Trial Details

NCT number	NCT01283581
Study type	Interventional
Source	Melinta Therapeutics, Inc.
Contact
Status	Completed
Phase	Phase 2
Start date	January 2011
Completion date	November 2011

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01421511` - TR-701 FA vs Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections	Phase 3
Active, not recruiting	`NCT02572791` - Staph Household Intervention for Eradication (SHINE)	Phase 4
Completed	`NCT01984684` - Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections	Phase 3
Completed	`NCT02796716` - Study of Accuracy of New Diagnostic Technology to Guide Rapid Antibiotic Treatment for Serious Infections	N/A
Completed	`NCT01519492` - A Study of Safety, Tolerability, and Efficacy of AFN-12520000 in the Treatment of Acute Bacterial Skin and Skin Structure Infections Due to Staphylococci	Phase 2
Completed	`NCT02060513` - Study of Accuracy of New Diagnostic Technology to Determine Guide Rapid Antibiotic Treatment for Serious Infections	N/A
Completed	`NCT01170221` - TR-701 FA vs. Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections.	Phase 3
Completed	`NCT01811732` - Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections	Phase 3
Completed	`NCT03964493` - TNP-2092 to Treat Acute Bacterial Skin and Skin Structure Infection	Phase 2